35
Views
48
CrossRef citations to date
0
Altmetric
Original Article

Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits

, , , &
Pages 791-797 | Received 06 Dec 1994, Accepted 12 May 1995, Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Zhou Wan, David F Woodward & W Daniel Stamer. (2008) Endogenous bioactive lipids and the regulation of conventional outflow facility. Expert Review of Ophthalmology 3:4, pages 457-470.
Read now
Natalya M. Kogan & Raphael Mechoulam. (2007) Cannabinoids in health and disease. Dialogues in Clinical Neuroscience 9:4, pages 413-430.
Read now
Iok-Hou Pang & Abbot F Clark. (2002) Advances in glaucoma therapeutics. Expert Opinion on Emerging Drugs 7:1, pages 141-163.
Read now
R. Jan Gurley, Richard Aranow & Mitchell Katz. (1998) Medicinal Marijuana: A Comprehensive Review. Journal of Psychoactive Drugs 30:2, pages 137-147.
Read now
T. Loftsson & E. Stefánsson. (1997) Effect of Cyclodextrins on Topical Drug Delivery to the Eye. Drug Development and Industrial Pharmacy 23:5, pages 473-481.
Read now

Articles from other publishers (43)

Miriam Kolko, Zaynab Ahmad Mouhammad & Barbara Cvenkel. (2023) Is fat the future for saving sight? Bioactive lipids and their impact on glaucoma. Pharmacology & Therapeutics 245, pages 108412.
Crossref
Alan Fulp, Sarah Bingham, Bethany Fisler, Felice Kho, Joshua Kim, So Jung Kim, Tabitha Martin, Bailey Mims, Kezia Reji Thomas, Grace Roe, Julia Spiotta, Julianna Young & Matthew Lazenka. (2022) Design and synthesis of endocannabinoid enzyme inhibitors for ocular indications. Bioorganic & Medicinal Chemistry Letters 68, pages 128763.
Crossref
Gabriele Gallo Afflitto, Francesco Aiello, Damiana Scuteri, Giacinto Bagetta & Carlo Nucci. (2022) CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review. Biomedicine & Pharmacotherapy 150, pages 112981.
Crossref
Leslie Rebibo, Marina Frušić-Zlotkin, Ron Ofri, Taher Nassar & Simon Benita. (2022) The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. International Journal of Pharmaceutics 617, pages 121627.
Crossref
Sally Miller, Laura Daily, Vijai Dharla, Juerg Gertsch, Michael S. Malamas, Iwao Ojima, Martin Kaczocha, Daisuke Ogasawara & Alex Straiker. (2020) Endocannabinoid metabolism and transport as targets to regulate intraocular pressure. Experimental Eye Research 201, pages 108266.
Crossref
Marita Pietrucha-Dutczak, Marialaura Amadio, Stefano Govoni, Joanna Lewin-Kowalik & Adrian Smedowski. (2018) The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration. Frontiers in Neuroscience 12.
Crossref
A. Aloway, A. Kumar, A.S. Laun & Z.H. Song. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies 748 759 .
Carlo Nucci, Rossella Russo, Alessio Martucci, Clarissa Giannini, Francesco Garaci, Roberto Floris, Giacinto Bagetta & Luigi Antonio Morrone. (2016) New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system. European Journal of Pharmacology 787, pages 119-126.
Crossref
Paula Urquhart, Jenny Wang, David F. Woodward & Anna Nicolaou. (2015) Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea. Journal of Lipid Research 56:8, pages 1419-1433.
Crossref
Robert Ramer & Burkhard Hinz. (2010) Cyclooxygenase-2 and tissue inhibitor of matrix metalloproteinases-1 confer the antimigratory effect of cannabinoids on human trabecular meshwork cells. Biochemical Pharmacology 80:6, pages 846-857.
Crossref
Juha Juntunen, Tomi Järvinen & Riku Niemi. (2005) In-vitro corneal permeation of cannabinoids and their water-soluble phosphate ester prodrugs. Journal of Pharmacy and Pharmacology 57:9, pages 1153-1157.
Crossref
Gerald W. Bean & Carl B. Camras. (2008) Commercially Available Prostaglandin Analogs for the Reduction of Intraocular Pressure: Similarities and Differences. Survey of Ophthalmology 53:6, pages S69-S84.
Crossref
IOK-HOU PANG & ABBOT F. CLARK. 2008. Ocular Therapeutics. Ocular Therapeutics 45 67 .
Pál Pacher, Sándor Bátkai & George Kunos. (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews 58:3, pages 389-462.
Crossref
Susanne Rösch, Robert Ramer, Kay Brune & Burkhard Hinz. (2006) R (+)-Methanandamide and Other Cannabinoids Induce the Expression of Cyclooxygenase-2 and Matrix Metalloproteinases in Human Nonpigmented Ciliary Epithelial Cells . Journal of Pharmacology and Experimental Therapeutics 316:3, pages 1219-1228.
Crossref
Friederike Stumpff, Marianne Boxberger, Achim Krauss, Rita Rosenthal, Susann Meissner, Lars Choritz, Michael Wiederholt & Hagen Thieme. (2005) Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork. Experimental Eye Research 80:5, pages 697-708.
Crossref
Gui-Lin Zhan, Carl B Camras, Paul F Palmberg & Carol B Toris. (2005) Effects of Marijuana on Aqueous Humor Dynamics in a Glaucoma Patient. Journal of Glaucoma 14:2, pages 175-177.
Crossref
Achim H.-P. Krauss & David F. Woodward. (2004) Update on the mechanism of action of bimatoprost: a review and discussion of new evidence. Survey of Ophthalmology 49:2, pages S5-S11.
Crossref
Chanjuan Shi, Anna Szczesniak, Lucy Mao, Christine Jollimore, Miguel Coca-Prados, Orlando Hung & Melanie E M Kelly. (2003) A3 adenosine and CB1 receptors activate a PKC-sensitive Cl − current in human nonpigmented ciliary epithelial cells via a Gβ γ -coupled MAPK signaling pathway . British Journal of Pharmacology 139:3, pages 475-486.
Crossref
Juha Juntunen, Juhani Huuskonen, Krista Laine, Riku Niemi, Hannu Taipale, Tapio Nevalainen, David W Pate & Tomi Järvinen. (2003) Anandamide prodrugs. European Journal of Pharmaceutical Sciences 19:1, pages 37-43.
Crossref
Krista Laine, Kristiina Järvinen & Tomi Järvinen. (2003) Topically administered CB2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits. Life Sciences 72:7, pages 837-842.
Crossref
Tomi Järvinen, David W Pate & Krista Laine. (2002) Cannabinoids in the treatment of glaucoma. Pharmacology & Therapeutics 95:2, pages 203-220.
Crossref
W.D Stamer, S.F Golightly, Y Hosohata, E.P Ryan, A.C Porter, E Varga, R.J Noecker, C.C Felder & H.I Yamamura. (2001) Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. European Journal of Pharmacology 431:3, pages 277-286.
Crossref
Douglas J Rhee, L.Jay Katz, George L Spaeth & Jonathan S Myers. (2001) Complementary and Alternative Medicine for Glaucoma. Survey of Ophthalmology 46:1, pages 43-55.
Crossref
Amy C. Porter & Christian C Felder. (2001) The endocannabinoid nervous system. Pharmacology & Therapeutics 90:1, pages 45-60.
Crossref
T. Bisogno, I. Delton-Vandenbroucke, A. Milone, M. Lagarde & V. Di Marzo. (1999) Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina. Archives of Biochemistry and Biophysics 370:2, pages 300-307.
Crossref
Keith Green. 1999. Marihuana and Medicine. Marihuana and Medicine 581 589 .
David W. Pate, Kristiina Järvinen, Arto Urtti, Vaidyanath Mahadevan & Tomi Järvinen. (1998) Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. Life Sciences 63:24, pages 2181-2188.
Crossref
Raphael Mechoulam, Ester Fride & Vincenzo Di Marzo. (1998) Endocannabinoids. European Journal of Pharmacology 359:1, pages 1-18.
Crossref
Luciano De PetrocellisDominique MelckAntonella PalmisanoTiziana BisognoChiara LaezzaMaurizio BifulcoVincenzo Di Marzo. (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proceedings of the National Academy of Sciences 95:14, pages 8375-8380.
Crossref
Anna Porcella, Pierre Casellas, Gian Luigi Gessa & Luca Pani. (1998) Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Molecular Brain Research 58:1-2, pages 240-245.
Crossref
Vincenzo Di Marzo. (1998) ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1392:2-3, pages 153-175.
Crossref
R. Mechoulam, L. Hanuš & Ester Fride. 1998. 199 243 .
C J Hillard & W B Campbell. (1997) Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. Journal of Lipid Research 38:12, pages 2383-2398.
Crossref
N.E Buckley, S Hansson, G Harta & É Mezey. (1997) Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82:4, pages 1131-1149.
Crossref
Nigel M Davies, Guangji Wang & Ian G Tucker. (1997) Evaluation of a hydrocortisone/hydroxypropyl-β-cyclodextrin solution for ocular drug delivery. International Journal of Pharmaceutics 156:2, pages 201-209.
Crossref
Cristina Sánchez, Guillermo Velasco & Manuel Guzmán. (1997) Metabolic stimulation of mouse spleen lymphocytes by low doses of 9-tetrahydrocannabinol. Life Sciences 60:19, pages 1709-1717.
Crossref
Esther Shohami, Joseph Weidenfeld, Haim Ovadia, Zvi Vogel, Lumir Harnuš, Ester Fride, Aviva Breuer, Shimon Ben‐Shabat, Tzviel Sheskin & Raphael Mechoulam. (2006) Endogenous and Synthetic Cannabinoids: Recent Advances. CNS Drug Reviews 2:4, pages 429-451.
Crossref
Evguenii V. Berdyshev, Elisabeth Boichot & Vincent Lagente. (1996) Anandamide—a new look on fatty acid ethanolamides. Journal of Lipid Mediators and Cell Signalling 15:1, pages 49-67.
Crossref
Roger A. Rajewski & Valentino J. Stella. (1996) Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery. Journal of Pharmaceutical Sciences 85:11, pages 1142-1169.
Crossref
Pekka Jarho, Arto Urtti, David W. Pate, Pekka Suhonen & Tomi Järvinen. (1996) Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-β-cyclodextrin. International Journal of Pharmaceutics 137:2, pages 209-216.
Crossref
David W. Pate, Kristiina Järvinen, Arto Urtti, Pekka Jarhol, Mette Fich, Vaidyanath Mahadevan & Tomi Järvinen. (1996) Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sciences 58:21, pages 1849-1860.
Crossref
P. Jarho, A. Urtti, D. W. Pate, P. Suhonen & T. Järvinen. 1997. Proceedings of the Eighth International Symposium on Cyclodextrins. Proceedings of the Eighth International Symposium on Cyclodextrins 395 398 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.